FDA Yet to be Convinced About Obesity Drug Qnexa

by Kathy Jones on  February 20, 2012 at 8:56 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

The US Food and Drug Administration has revealed that it is not yet convinced that the obesity drug manufactured by Vivus Inc is safe for use.
 FDA Yet to be Convinced About Obesity Drug Qnexa
FDA Yet to be Convinced About Obesity Drug Qnexa

The FDA had earlier rejected the application for approval of the drug, Qnexa, back in October 2010 and had asked Vivus for additional information regarding its clinical trials.

However the agency is not satisfied with the information and believes that the drug could lead to health problems due to long term use and can also cause birth defects.

An advisory panel for the FDA will be meeting on February 22 to review two years worth of clinical data before deciding whether to recommend the agency to approve the drug or not. The FDA said that while the drug has demonstrated loss of weight in its users, concerns of birth defects and accelerated heartbeat still remains.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Bariatric Surgery Drug Toxicity Obesity Bulimia Nervosa Body Mass Index Signature Drug Toxicity Liposuction Battle of the Bulge Diabesity Hunger Fullness and Weight Control 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...